European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
Pregnancy-associated breast malignancy mostly presents with an aggressive type of breast cancer
Pregnancy-associated breast malignancy mostly presents with an aggressive type of breast cancer
DOI: 10.22514/ejgo.2023.069
iTRAQ-based proteomics analysis reveals novel candidates for platinum resistance of epithelial ovarian cancer
iTRAQ-based proteomics analysis reveals novel candidates for platinum resistance of epithelial ovarian cancer
DOI: 10.22514/ejgo.2023.074
Impact of percutaneous nephrostomy on clinical outcomes in advanced carcinoma cervix with obstructive uropathy at Kenyatta national hospital
Impact of percutaneous nephrostomy on clinical outcomes in advanced carcinoma cervix with obstructive uropathy at Kenyatta national hospital
DOI: 10.22514/ejgo.2023.075
BRD4 inhibitor JQ1 may affect the prognosis of cervical cancer through super-enhancer-related genes
BRD4 inhibitor JQ1 may affect the prognosis of cervical cancer through super-enhancer-related genes
DOI: 10.22514/ejgo.2023.076
Analysis of risk factors and construction and validation of a predictive model for determining the risk of endometrial cancer in postmenopausal patients with abnormal uterine bleeding
Analysis of risk factors and construction and validation of a predictive model for determining the risk of endometrial cancer in postmenopausal patients with abnormal uterine bleeding
DOI: 10.22514/ejgo.2023.077
Evaluation of the relationship of the amount of ascites as measured quantitatively using computed tomography with chemotherapy toxicity in patients with ovarian cancer
Evaluation of the relationship of the amount of ascites as measured quantitatively using computed tomography with chemotherapy toxicity in patients with ovarian cancer
DOI: 10.22514/ejgo.2023.078
Development of a novel transcription factor signature for accurate cervical cancer prognosis
Development of a novel transcription factor signature for accurate cervical cancer prognosis
DOI: 10.22514/ejgo.2023.079
Dezocine inhibits proliferation as well as migration of endometrial carcinoma in vitro
Dezocine inhibits proliferation as well as migration of endometrial carcinoma in vitro
DOI: 10.22514/ejgo.2023.081
Effects of different doses of esketamine on hemodynamic indexes, pain stress indexes, and VAS scores in patients with benign ovarian tumors undergoing laparoscopic resection induced by remifentanil
Effects of different doses of esketamine on hemodynamic indexes, pain stress indexes, and VAS scores in patients with benign ovarian tumors undergoing laparoscopic resection induced by remifentanil
DOI: 10.22514/ejgo.2023.082
Ultrasound-guided thoracic paravertebral nerve block in patients undergoing radical mastectomy
Ultrasound-guided thoracic paravertebral nerve block in patients undergoing radical mastectomy
DOI: 10.22514/ejgo.2023.083
Predictive value of HPV genotyping for recurrence of CIN2−3 in women treated by LEEP with negative resection margins
Predictive value of HPV genotyping for recurrence of CIN2−3 in women treated by LEEP with negative resection margins
DOI: 10.22514/ejgo.2023.047
The value of ultrasonic parameters combined with clinicopathological parameters in predicting axillary lymph node metastasis in triple-negative breast cancer
The value of ultrasonic parameters combined with clinicopathological parameters in predicting axillary lymph node metastasis in triple-negative breast cancer
DOI: 10.22514/ejgo.2023.084
Tumor growth inhibition and tumor specific immunity enhancement in endometrial carcinoma by high intensity focused ultrasound
Tumor growth inhibition and tumor specific immunity enhancement in endometrial carcinoma by high intensity focused ultrasound
DOI: 10.22514/ejgo.2023.085
High expression of SPINT2 promotes immune infiltration and tumor progression in ovarian cancer
High expression of SPINT2 promotes immune infiltration and tumor progression in ovarian cancer
DOI: 10.22514/ejgo.2023.086
Inhibition of MARK2 inhibits ovarian cancer cell proliferation by regulating PI3K/AKT/p53 axis
Inhibition of MARK2 inhibits ovarian cancer cell proliferation by regulating PI3K/AKT/p53 axis
DOI: 10.22514/ejgo.2023.088
Overexpression of USP43 induces the growth and stem cell-like properties of cervical cancer by activating ERK1/2 through ZEB1
Overexpression of USP43 induces the growth and stem cell-like properties of cervical cancer by activating ERK1/2 through ZEB1
DOI: 10.22514/ejgo.2023.089
Evaluation of bone health in breast cancer patients with
germline pathogenic variants
Evaluation of bone health in breast cancer patients with germline pathogenic variants
DOI: 10.22514/ejgo.2023.090
Human papilloma virus associated primary vaginal adenocarcinoma
Human papilloma virus associated primary vaginal adenocarcinoma
DOI: 10.22514/ejgo.2023.091
Published Ahead of Print
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Online publish date: 12 October 2023
DOI: 10.22514/ejgo.2023.073
Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services
Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.071
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Vulvar cancer in young woman—case report
Vulvar cancer in young woman—case report
Online publish date: 07 September 2023
DOI: 10.22514/ejgo.2023.070
Prognostic value of Ki-67 in patients with ovarian cancer
Prognostic value of Ki-67 in patients with ovarian cancer
Online publish date: 24 July 2023
DOI: 10.22514/ejgo.2023.051
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.